Previous studies indicated the involvement of bone marrow-derived myeloid cells in GBM development and CSF1R inhibition decreased cytokines that are involved in inflammation, angiogenesis, invasion, and proliferation, which eventually decreased GBM growth [10, 11, 46]. This evidence concerns the gene CSF1R and glioblastoma.